Page last updated: 2024-12-06

o(6)-methyl-2'-deoxyguanosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O(6)-methyl-2'-deoxyguanosine: RN given refers to (beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O(6)-methyl-2'-deoxyguanosine : A purine 2'-deoxyribonucleoside having O(6)-methylguanine as the nucleobase. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID73317
CHEBI ID27549
SCHEMBL ID657819
MeSH IDM0064917

Synonyms (31)

Synonym
o6-methyl-2 -deoxyguanosine
BIDD:GT0852
9-(2-deoxy-beta-d-erythro-pentofuranosyl)-6-methoxy-9h-purin-2-amine
2'-deoxy-o(6)-methylguanosine
o(6)-methyldeoxyguanosine
o(6)-methyl-2'-deoxyguanosine
CHEBI:27549 ,
964-21-6
o6-methyl-dg
(2r,3s,5r)-5-(2-amino-6-methoxy-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
o6-methyl-2-deoxyguanosine
o6-methyl-2'-deoxyguanosine
C05031 ,
(2r,3s,5r)-5-(2-amino-6-methoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
guanosine, 2'-deoxy-6-o-methyl-
EPITOPE ID:146099
SCHEMBL657819
BCKDNMPYCIOBTA-RRKCRQDMSA-N
2-amino-6-methoxy-9-(2-deoxy-beta-d-erythro-pentofuranosyl)purine
o6 -methyldeoxyguanosine
o6-methyl-deoxyguanosine
6-o-methyl-2'-deoxyguanosine
o6-methyldeoxyguanosine
guanosine,2'-deoxy-6-o-methyl-
DTXSID60242222
(2r,3s,5r)-5-(2-amino-6-methoxy-9h-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
Q27103189
(2~{r},3~{s},5~{r})-5-(2-azanyl-6-methoxy-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
J03 ,
(2r,3s,5r)-5-(2-amino-6-methoxy-9h-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
2'-deoxy-n2-methyl-d-guanosine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Hence, dosing with DAS or feeding garlic may be useful chemopreventive strategies against nitrosamine-induced cancers."( Inhibition by allyl sulfides and crushed garlic of O6-methylguanine formation in liver DNA of dimethylnitrosamine-treated rats.
Mirvish, SS; Zhou, L, 2005
)
0.33
" For xenobiotics that generate adducts without background, the difference is even more pronounced because the dose-response curve starts at zero and the limit of detection of an increase is not affected by background variation."( Biological significance of DNA adducts investigated by simultaneous analysis of different endpoints of genotoxicity in L5178Y mouse lymphoma cells treated with methyl methanesulfonate.
Brink, A; Lutz, WK; Schulz, B; Stopper, H, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
purine 2'-deoxyribonucleosideA 2'-deoxyribonucleoside that has a purine moiety as the nucleobase (the R group in the illustration).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (73)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (28.77)18.7374
1990's30 (41.10)18.2507
2000's13 (17.81)29.6817
2010's8 (10.96)24.3611
2020's1 (1.37)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.12 (24.57)
Research Supply Index4.32 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.37%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (98.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]